Category: Africa

Posted on

Supercar Rental Company Classic Parade Launches UK’s First Cryptocurrency Payment Service

Supercar Rental Company Classic Parade Launches UK’s First Cryptocurrency Payment Service

One of the UK’s leading supercar hire companies has just launched a cryptocurrency payment system to rent the world’s most impressive supercars.

LONDON, Feb. 21, 2023 (GLOBE NEWSWIRE) — One of the UK’s leading supercar hire companies has just launched a cryptocurrency payment system to rent the world’s most impressive supercars. Customers can now choose to pay to for selection of over 100 supercars from 28 luxury marques in Bitcoin or Ethereum cryptocurrency as well as in Pound Sterling. One of the cars available at their showrooms in London, Manchester and Edinburgh, is the £2.4m Bugatti Chiron, which costs £200,000 a day to rent, or 220.75 ETH, or 11.696 BTC.

Classic Parade founder and owner Andrew Brown said: “Our clientele are international and want to be able to pay to rent our supercars without the hassle and cost of exchange rates and transfer fees. “Many of our clientele have significant holdings in cryptocurrency and so it makes sense to offer this option for them. The transactions are immediate, and we can also take the deposits in crypto as well, and then it’s easy to return the deposit after the rental has expired as well.”

jpg

Crypto payments are made to Classic Parade’s secure wallet and all necessary steps are taken to ensure the safety of the financial transfers. Once the funds have transferred and the rental agreements are signed the supercar is either collected or delivered to the customers address in the UK.

Andrew Brown added: “We have to go through the usual identity checks needed to hire a vehicle, but these are easy to process, and it becomes much easier with every repeat transaction. “This way we can also provide adequate “know your customer” checks.” One of Classic Parade’s most popular cars for summer rentals is the Lamborghini Huracan Spyder which costs £1,100 a day to rent, or 1.21 ETH or 0.064 BTC. Andrew Brown said: “We are expecting a great deal of interest from crypto investors in the next few months to rent out our incredible supercars. Many investors are relatively young and want to show their wealth and so the interest in supercars is very strong for this market.”

You can see the full range of supercars and their prices at https://www.classicparade.co.uk

Media contact details:

James Goble, Classic Parade
+44 (0) 333 355 3595
rent@classicparade.co.uk

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/49b34c75-e25e-4725-bd2c-0b83c37cfe83

GlobeNewswire Distribution ID 1000783903

Posted on

Hisense Brings Its Most Family-friendly Big-screen 90L5H Laser TV to South Africa

CAPE TOWN, South Africa, Feb. 15, 2023 /PRNewswire/ — Leading global electronics brand Hisense is preparing to deliver a revolutionary viewing experience to homes in South Africa with the local launch of its 90L5H 4K Laser TV. Featuring a palette of more than 16.7 million colors, the product brings true-to-life pictures with outstanding realism and accuracy.

Billed as the company’s most family-friendly big-screen TV, the 90L5H packs quite the punch with a 90-inch screen and 8.3 million pixels featuring the company’s groundbreaking X-Fusion Laser Technology and Dolby Atmos multidimensional sound. The product is the perfect choice for a wide range of customers, whether they are avid movie fans looking for the best big-screen experience, sports fans trying to get closer to the action, or gamers looking for the best way to view graphics. The six-foot-wide 90L5H has something to offer users across a diverse mixture of demographics, from kids and teenagers to professionals who enjoy the finer things in life.

By employing a combination of the company’s X-Fusion Laser Technology and ultra-short throw projection technology, Hisense achieves razor-sharp imagery on the 90L5H TV, bringing families a unique atmosphere in their own homes that is not dissimilar to the full-on cinematic experience. Despite its size, the product really punches above its weight in terms of performance. It features a reflective display and low-blue light to ensure that users will not feel the strain on their eyes during prolonged viewing sessions and all this comes without sacrificing the original display quality.

However, Hisense’s investment in performance does not stop there. The company used its Ambient Light Rejecting technology to strengthen colors further, and users don’t need to kill the lights to ensure a crystal clear and striking picture quality. Additionally, the high native contrast with a native rate of 3,000:1 makes those on-screen highlights even more punchy, delivering for users in terms of depth and realism for shadowy imagery on screen.

The team at Hisense pursued a sleek and attractive ergonomic when designing the 90L5H, and the result is a product that would not look out of place in most rooms anywhere in the house. Under the hood, the sturdy aluminum frame and scratch-resistance surface combine a favorable aesthetic with solid performance, and it all weighs only 20 pounds.

In terms of flexibility for users, the TV supports HDR10, HLG, and Dolby Vision while leveraging High Dynamic Range to transfer its ability to display such strong colors to supported content. Additionally, Filmmaker Mode is on hand to bring users a more authentic viewing experience. The mode deactivates some of the picture and motion technology settings to revert the viewing experience back to how the creator intended it to be, putting the user completely in control of image quality.

For more information, please check: https://hisense.co.za/products/hisense-90-4k-laser-tv-90l5h/

Photo – https://mma.prnewswire.com/media/2002871/90L5H_KV.jpg

Posted on

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

London, U.K., Feb. 13, 2023 (GLOBE NEWSWIRE) — OPEN Health, a pre-eminent global provider of scientific communications and HEOR & market access services, announced the acquisition of Acsel Health (“Acsel”), a New York-based life science strategy and advisory firm focused on commercial strategy, pricing and market access, and commercial excellence.

Acsel’s deep industry expertise, scientific rigor, and actionable analysis drives its success in providing valued partnership to life science companies. These capabilities will complement OPEN Health’s existing offering, broadening the range of services it offers to pharma and biotech companies.

Lujing Wang, Managing Partner of Acsel Health, said, “We are thrilled to join OPEN Health and to work with a wider team to solve for today’s demands and meet tomorrow’s expectations for pharma and biotech customers. With new colleagues and capabilities to partner with, we are equipped to answer the most challenging cross-disciplinary questions in life science across all key therapeutic areas.”

“Acsel is an extraordinary addition to OPEN Health. Acsel’s expert team and long-standing client relationships significantly strengthen our ability to support the commercialization of our clients’ assets and unlock access for patients.” said OPEN Health CEO, Rob Barker. “We are excited to welcome Acsel Health into the OPEN Health Group and look forward to working with our new colleagues to offer our clients innovative, scientific solutions around the globe.”

Fairmount Partners acted as exclusive financial advisor to Acsel Health. The terms of the transaction were not disclosed.

About OPEN Health

OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient wellbeing. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across HEOR and market access, medical communications and creative omnichannel campaigns. For more information on OPEN Health, visit www.openhealthgroup.com.

About Acsel Health

Acsel Health is a consulting firm that partners with renowned life science companies to guide life-changing innovations through their critical stages, from early development through market maturity. Acsel applies best-practice principles to develop and deliver highly individualized solutions to challenges across the product lifecycle for our clients. For more information on Acsel Health, visit www.acselhealth.com.

Attachment

Candice Subero
OPEN Health
candicesubero@openhealthgroup.com

GlobeNewswire Distribution ID 8744608

Posted on

PowerChina-constructed Mali Gouina hydropower station completed

Alleviating electricity shortages in West Africa

BEIJING, Feb. 10, 2023 /PRNewswire/ — A news report by haiwainet.cn:

On December 3, 2022, the inauguration of the Gouina Hydropower Station, which is owned and managed by the Organization for the Development of the Senegal River (OMVS), financed by the Export-Import Bank of China, and constructed by PowerChina, was held in the Diamou area of the Kayes region.

The inauguration was co-chaired by Colonel Abdoulaye Maïga, Acting Prime Minister of the Republic of Mali. He warmly congratulated the successful completion of the Gouina hydropower station, thanks to the Chinese government and the Chinese Embassy in Mali for their strong support for the power construction in Mali and even West Africa. He also thanked PowerChina for its contribution to the project implementation.

The Gouina Hydropower Station falls along the Senegal River in Mali. The dam is 19 meters high, with a total length of 1317 meters and a storage capacity of 136 million cubic meters. It took 6 years to complete the construction. According to PowerChina, the Gouina Hydropower Station is one of the largest construction projects invested by Chinese companies in Mali.

As a large-scale infrastructure project in the area involved in the “Belt and Road” initiative, once operational, the station is expected to generate about 621 million kilowatt-hours of power. It will form a cascade reservoir and stations with Manantali and Felou hydropower stations, contributing to a continuous and stable power grid covering a large region. The grid will overcome power shortages in Mali and boost local industrial and social and economic development. Besides Mali, the grid will send power to Senegal and Mauritania in West Africa, which will improve local people’s quality of life.

In 2003, the Mali office of PowerChina was officially established, and PowerChina’s first bridge project entered the Mali market. In 2009, PowerChina acquired the Felou Hydropower Station under the framework of OMVS through IOB. Up to now, PowerChina has set up six regional headquarters, 453 branches in more than 120 countries around the world.

Posted on

Keyron appoints new Chief Executive Officer

Carl D Francis takes the helm at medtech group focused on reversal of diabetes, NASH, and obesity

LONDON, Feb. 07, 2023 (GLOBE NEWSWIRE) — Today Keyron, the medical technology group focused on reversing type 2 diabetes, non-alcoholic steatohepatitis (NASH), and obesity via an innovative medical device platform, announced the appointment of Carl D Francis as Chief Executive Officer.

“The continuing rise in obesity, diabetes, and all forms of fatty liver disease is one of the biggest health challenges the world faces today. Literally billions of people are affected, and the numbers continue to rise rapidly,” Francis said. “Keyron’s technology is a complete game-changer. An innovative, non-surgical, endoscopically-delivered, fully reversible treatment as an alternative to drastic bariatric surgeries is as exciting as it gets. I am really proud and honoured to be part of Keyron.”

The American Diabetes Association states that today 37m Americans suffer from diabetes, with 96m having pre-diabetes. The link between obesity and diabetes is well established, and according to The World Obesity Federation’s forecast in their recently released 2022 Atlas, 67% of women and 51% of men in the Americas will be living with obesity (BMI ≥ 30) by 2030.

Keyron’s patented technology is designed to be a fully endoscopic, outpatient procedure providing the same or greater metabolic benefits of gastric bypass surgery, including a reversal of type 2 diabetes and obesity, as well as NASH and liver fibrosis.

Following successful rodent studies in 2019 and swine studies in 2022, Keyron’s first-in-human trials are planned to begin in early 2024. Keyron is targeting to achieve FDA clearance by 2028, and a US launch is planned as the first target market. The company is now making plans to raise a $15m Series A funding round.

Dr Giorgio Castagneto Gissey, Keyron’s Chairman, said, “We are thrilled that Carl will be leading Keyron as we enter this critical stage of our development. Carl brings energy, focus, and senior leadership experience to ensure we realize our full potential. Keyron has always had high profile, world-leading board members and medical advisors, and we continue to bring onboard remarkable people. We are truly delighted to have been able to attract Carl.”

Francis was previously CEO of successful nano-technology group P2i. During his tenure the group grew from a handful of employees to global leadership in the functional nano-coating space. He was most recently CEO of UK-based medtech group Eyoto which specializes in advanced technologies in the optical and ophthalmic industries. He started his career as a US CPA, is a member of Mensa, and has a BSc from the University of Cincinnati.

CONTACT

For further information please contact:

ABOUT KEYRON

Keyron is a UK-based, preclinical-stage medical device and technology platform company aimed at a highly-effective treatment of metabolic diseases. Keyron’s patented ForePass™ is an innovative medical device designed to safely reverse type-2 diabetes, as well as NASH, and obesity. The company has already demonstrated a full reversal of insulin resistance in animal studies, and recently published the results in The Lancet EBioMedicine. Keyron has upcoming clinical trials in South America and aims to then carry out further clinical trials in the USA. Its founders, directors, advisors and investors include some of the most well-known and cited professors and KOLs worldwide in the metabolic diseases space. The company is backed by multiple institutional investors based in the USA and EMEA.

GlobeNewswire Distribution ID 8743797

Proudly powered by WordPress